Pharvaris to Present at the WSAAI Annual Meeting 2024

ZUG, Switzerland, Jan. 26, 2024 -- Pharvaris , a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks, today...

Related Keywords

Hawaii ,United States ,Switzerland ,Marca Riedl ,Joshuas Jacobs , ,Society Of Allergy ,Western Society ,Annual Meeting ,Grand Hyatt Kauai Resort ,Deucrictibant Immediate Release Capsule ,Hereditary Angioedema Attacks ,Early Onset Response ,Hereditary Angioedema ,Markets ,